0001209191-18-036178.txt : 20180606 0001209191-18-036178.hdr.sgml : 20180606 20180606195730 ACCESSION NUMBER: 0001209191-18-036178 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180604 FILED AS OF DATE: 20180606 DATE AS OF CHANGE: 20180606 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vaughn James J CENTRAL INDEX KEY: 0001649689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 18884978 MAIL ADDRESS: STREET 1: C/O GENOMIC HEALTH, INC. STREET 2: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-04 0 0001131324 GENOMIC HEALTH INC GHDX 0001649689 Vaughn James J 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063 0 1 0 0 Chief Commercial Officer Common Stock 2018-06-04 4 M 0 9000 22.98 A 38655 D Common Stock 2018-06-04 4 S 0 9000 43.8708 D 29655 D Common Stock 2018-06-04 4 M 0 13500 27.48 A 43155 D Common Stock 2018-06-04 4 S 0 10977 44.6691 D 32178 D Common Stock 2018-06-04 4 S 0 2523 45.4689 D 29655 D Common Stock 2018-06-04 4 M 0 20000 27.00 A 49655 D Common Stock 2018-06-04 4 S 0 7552 46.0652 D 42103 D Common Stock 2018-06-04 4 S 0 12448 46.8261 D 29655 D Common Stock 2018-06-04 4 M 0 16268 28.05 A 45923 D Common Stock 2018-06-04 4 S 0 9639 47.5743 D 36284 D Common Stock 2018-06-04 4 S 0 6629 48.3285 D 29655 D Common Stock 2018-06-04 4 M 0 12000 29.34 A 41655 D Common Stock 2018-06-04 4 S 0 12000 48.5736 D 29655 D Common Stock 2018-06-04 4 M 0 10000 17.18 A 39655 D Common Stock 2018-06-04 4 S 0 10000 43.4088 D 29655 D Common Stock 2018-06-04 4 S 0 8594 43.4209 D 21061 D Common Stock 2018-06-04 4 S 0 4052 43.542 D 17009 D Employee Stock Option (right to buy) 17.18 2018-06-04 4 M 0 10000 0.00 D 2020-02-18 Common Stock 0 0 D Employee Stock Option (right to buy) 22.98 2018-06-04 4 M 0 9000 0.00 D 2021-01-27 Common Stock 0 0 D Employee Stock Option (right to buy) 29.34 2018-06-04 4 M 0 12000 0.00 D 2022-02-05 Common Stock 0 0 D Employee Stock Option (right to buy) 28.05 2018-06-04 4 M 0 16268 0.00 D 2023-01-31 Common Stock 0 3732 D Employee Stock Option (right to buy) Holding 27.00 2018-06-04 4 M 0 20000 0.00 D 2026-02-16 Common Stock 0 41700 D Employee Stock Option (right to buy) Holding 27.48 2018-06-04 4 M 0 13500 0.00 D 2027-01-31 Common Stock 0 40580 D Includes an aggregate of 15,534 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 9, 2018. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Represents weighted average sale price. Actual sale prices ranged from $43.68 to $44.23. Represents weighted average sale price. Actual sale prices ranged from $44.23 to $45.14. Represents weighted average sale price. Actual sale prices ranged from $45.32 to $45.61. Represents weighted average sale price. Actual sale prices ranged from $45.61 to $46.60. Represents weighted average sale price. Actual sale prices ranged from $46.64 to $47.10. Represents weighted average sale price. Actual sale prices ranged from $47.10 to $48.08. Represents weighted average sale price. Actual sale prices ranged from $48.16 to $48.40. Represents weighted average sale price. Actual sale prices ranged from $48.40 to $48.79. These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 8, 2017. Represents weighted average sale price. Actual sale prices ranged from $43.20 to $43.51. Represents weighted average sale price. Actual sale prices ranged from $43.25 to $43.68. Represents weighted average sale price. Actual sale prices ranged from $43.51 to $43.66. The option became exercisable as to 25% of the shares on February 18, 2011, and became exercisable as to 1/48th of the shares each full month thereafter. The option became exercisable as to 25% of the shares on January 27, 2012, and became exercisable as to 1/48th of the shares each full month thereafter. The option became exercisable as to 25% of the shares on February 5, 2013, and became exercisable as to 1/48th of the shares each full month thereafter. The option became exercisable as to 25% of the shares on January 31, 2014, and becomes exercisable as to 1/48th of the shares each full month thereafter. The option became exercisable as to 25% of the shares on February 16, 2017, and became exercisable as to 1/48th of the shares each full month thereafter. The option became exercisable as to 25% of the shares on January 31, 2018, and becomes exercisable as to 1/48th of the shares each full month thereafter. /s/ Jason W.Radford, Attorney-in-fact 2018-06-06